Ibrance — Medical Mutual
Other indications cited in the NCCN guidelines as a category 1, 2A, or 2B recommendation
Preferred products
- Verzenio
- Kisqali
- Kisqali Femara Co-Pack
Initial criteria
- Prescribed by or in consultation with a hematologist or oncologist
- Prescriber will provide specific diagnosis for documentation
Approval duration
1 year initial, 1 year reauth